IP Verse

University Of Washington Through Its Center For Commercialization patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of University Of Washington Through Its Center For Commercialization opposed by its competitors

Explore University Of Washington Through Its Center For Commercialization's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2838548
Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof2
EP2828218
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing3
EP2699593
Nov 4, 2020Beta-2 Microglobulin-Deficient Cells1

Top competitors of University Of Washington Through Its Center For Commercialization

Top competitors of University Of Washington Through Its Center For Commercialization based on patent oppositions.